Cancer clinical trials in the region Grand Est
211 currently recruiting clinical trials
Looking for clinical trials?
Clinical trial search is a complex process, with countless criteria to consider. Our AI assistant navigates this complexity with precise, expert-level analysis of the most relevant trials based on your medical profile. Our database is fully up to date, so you see only actively recruiting sites. It's fast and easy:
- Create your account
- Copy-paste your latest medical report
- Our AI-based assistant does the rest for you
Whether you are a patient or a doctor, create an account to find and apply for the most relevant clinical trials:
Phase 2
Kidney cancer
#NCT05865730
#2024-516711-24-00
Clear cell carcinoma
Locally Advanced
Metastatic
ICANS - Institut de cancérologie Strasbourg Europe (Strasbourg)
EverImmune
Phase 2
Breast cancer
#NCT06172478
#2023-507641-29-00
HER2 Negative
HR Positive
Locally Advanced
Metastatic
1
Chemotherapy
Targeted therapy
Hormone therapy
ALK
BRAF
EGFR
HER2
KRAS G12C
MET
NTRK-1/2/3
RET
ROS-1
Systemic Treatment-Naive
Institut de Cancérologie de Lorraine - Alexis Vautrin (Vandœuvre-lès-Nancy)
Daiichi Sankyo
Phase 2
Lung cancer
#NCT05865730
#2024-516711-24-00
NSCLC (Non-Small Cell Lung Cancer)
Non-squamous NSCLC
Metastatic
PDL1 Positive (>= 50%)
ICANS - Institut de cancérologie Strasbourg Europe (Strasbourg)
EverImmune
Phase 2
Stomach and esophageal cancer
#NCT06172478
#2023-507641-29-00
Stomach
Oesogastric junction
Locally Advanced
Metastatic
1
Chemotherapy
HER2
Systemic Treatment-Naive
Institut de Cancérologie de Lorraine - Alexis Vautrin (Vandœuvre-lès-Nancy)
Daiichi Sankyo
Phase 2
Prostate cancer
#NCT05849298
#2022-503040-41-00
PSMA PET Positive
1
Hormone therapy
Hormone therapy
Systemic Treatment-Naive
Immunotherapy
Internal Vectorised Radiotherapy (IVR)
Systemic Treatment-Naive
Immunotherapy
Internal Vectorised Radiotherapy (IVR)
ICANS - Institut de cancérologie Strasbourg Europe (Strasbourg)
Novartis
Phase 2
Lymphoma
#NCT04984837
#2024-513252-15-00
T cell lymphoma
Peripheral T cell lymphoma
None
> 60 ml/min
50-60 ml/min
30-50 ml/min
1
2
Chemotherapy
Systemic Treatment-Naive
Allogeneic stem cell transplant
CHRU de Nancy - Hôpitaux de Brabois (Vandœuvre-lès-Nancy), ICANS - Institut de cancérologie Strasbourg Europe (Strasbourg), Ghrmsa - Hôpital Emile Muller (Mulhouse), CHU Reims (Reims)
The Lymphoma Academic Research Organisation (LYSARC)
Phase 2
Bladder / Urinary Tract / Urethral cancer
#NCT06172478
#2023-507641-29-00
Invasive bladder cancer
Non-invasive bladder cancer
Upper excretory tract cancer
Urethral cancer
Locally Advanced
Metastatic
1
2
3 or more
Immunotherapy
Chemotherapy
Systemic Treatment-Naive
Institut de Cancérologie de Lorraine - Alexis Vautrin (Vandœuvre-lès-Nancy)
Daiichi Sankyo
Phase 2
Stomach and esophageal cancer
#NCT06172478
#2023-507641-29-00
Esophagus
Squamous cell carcinoma
Locally Advanced
Metastatic
2
Chemotherapy
Systemic Treatment-Naive
Institut de Cancérologie de Lorraine - Alexis Vautrin (Vandœuvre-lès-Nancy)
Daiichi Sankyo
Phase 2
Kidney cancer
#NCT05096390
#2024-513986-38-00
Papillary carcinoma
Locally Advanced
Metastatic
None
Systemic Treatment-Naive
Systemic Treatment-Naive
Institut de Cancérologie de Lorraine - Alexis Vautrin (Vandœuvre-lès-Nancy)
Centre Léon Bérard
Phase 2
Prostate cancer
#NCT06004661
Metastatic Castration-resistant
PSMA PET Positive
1
Hormone therapy
Systemic Treatment-Naive
Internal Vectorised Radiotherapy (IVR)
CHRU de Nancy - Hôpitaux de Brabois (Vandœuvre-lès-Nancy)
Novartis